Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo-Reference-Cited by-同舟云学术

Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo

Published:2013-06-10 Issue:6 Volume:8 Page:e66825
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ogbomo Henry,Zemp Franz J.,Lun Xueqing,Zhang Jiqing,Stack Danuta,Rahman Masmudur M.,Mcfadden Grant,Mody Christopher H.,Forsyth Peter A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;R Stupp;Lancet Oncol,2009

2. Vauleon E, Avril T, Collet B, Mosser J, Quillien V (2010) Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol2010..

3. Malignant glioma: neuropathology and neurobiology;M Preusser;Wien Med Wochenschr,2006

4. Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells;CA Alvarez-Breckenridge;Adv Virol,2012

5. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus;RM Diaz;Cancer Res,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumors;EJC Paediatric Oncology;2024-06

2. Constructing a Nucleotide Metabolism Related Prognostic Model Based on Bioinformatics to Explore the Potential Molecular Mechanisms of Glioblastoma;2024-04-18

3. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies;Medical Sciences;2023-12-23

4. Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies;Viruses;2023-02-16

5. Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme;MedComm – Oncology;2023-01-31